Risk of alanine transferase (ALT) elevation in patients with rheumatoid arthritis treated with methotrexate in a DAS-steered strategy

L. Dirven; N.B. Klarenbeek; M. van den Broek; J.H.L.M. Groenendael; P.B.J. de Sonnaville; P.J.S.M. Kerstens; T.W.J. Huizinga; B.A.C. Dijkmans; W.F. Lems; C.F. Allaart

doi:https://doi.org/10.1007/s10067-012-2136-8

Risk of alanine transferase (ALT) elevation in patients with rheumatoid arthritis treated with methotrexate in a DAS-steered strategy

L. Dirven, N.B. Klarenbeek, M. van den Broek, J.H.L.M. Groenendael, P.B.J. de Sonnaville, P.J.S.M. Kerstens, T.W.J. Huizinga, B.A.C. Dijkmans, W.F. Lems, C.F. Allaart

Rheumatology (VUmc)

Research output: Contribution to journal › Article › Academic › peer-review

17 Citations (Scopus)

Original language	English
Pages (from-to)	585-590
Journal	Clinical Rheumatology
Volume	32
Issue number	5
DOIs	https://doi.org/10.1007/s10067-012-2136-8
Publication status	Published - 2013

Access to Document

https://doi.org/10.1007/s10067-012-2136-8

Cite this

Dirven, L., Klarenbeek, N. B., van den Broek, M., Groenendael, J. H. L. M., de Sonnaville, P. B. J., Kerstens, P. J. S. M., Huizinga, T. W. J., Dijkmans, B. A. C., Lems, W. F., & Allaart, C. F. (2013). Risk of alanine transferase (ALT) elevation in patients with rheumatoid arthritis treated with methotrexate in a DAS-steered strategy. Clinical Rheumatology, 32(5), 585-590. https://doi.org/10.1007/s10067-012-2136-8

@article{97d4cbda4b64471489062422c4f59109,

title = "Risk of alanine transferase (ALT) elevation in patients with rheumatoid arthritis treated with methotrexate in a DAS-steered strategy",

author = "L. Dirven and N.B. Klarenbeek and {van den Broek}, M. and J.H.L.M. Groenendael and {de Sonnaville}, P.B.J. and P.J.S.M. Kerstens and T.W.J. Huizinga and B.A.C. Dijkmans and W.F. Lems and C.F. Allaart",

year = "2013",

doi = "https://doi.org/10.1007/s10067-012-2136-8",

language = "English",

volume = "32",

pages = "585--590",

journal = "Clinical Rheumatology",

issn = "0770-3198",

publisher = "Springer London",

number = "5",

}

Dirven, L, Klarenbeek, NB, van den Broek, M, Groenendael, JHLM, de Sonnaville, PBJ, Kerstens, PJSM, Huizinga, TWJ, Dijkmans, BAC , Lems, WF & Allaart, CF 2013, 'Risk of alanine transferase (ALT) elevation in patients with rheumatoid arthritis treated with methotrexate in a DAS-steered strategy', Clinical Rheumatology, vol. 32, no. 5, pp. 585-590. https://doi.org/10.1007/s10067-012-2136-8

TY - JOUR

T1 - Risk of alanine transferase (ALT) elevation in patients with rheumatoid arthritis treated with methotrexate in a DAS-steered strategy

AU - Dirven, L.

AU - Klarenbeek, N.B.

AU - van den Broek, M.

AU - Groenendael, J.H.L.M.

AU - de Sonnaville, P.B.J.

AU - Kerstens, P.J.S.M.

AU - Huizinga, T.W.J.

AU - Dijkmans, B.A.C.

AU - Lems, W.F.

AU - Allaart, C.F.

PY - 2013

Y1 - 2013

U2 - https://doi.org/10.1007/s10067-012-2136-8

DO - https://doi.org/10.1007/s10067-012-2136-8

M3 - Article

C2 - 23224330

SN - 0770-3198

VL - 32

SP - 585

EP - 590

JO - Clinical Rheumatology

JF - Clinical Rheumatology

IS - 5

ER -